Article
TarO-specific inhibitors of wall teichoic acid biosynthesis restore β-lactam efficacy against methicillin-resistant staphylococci.
Science translational medicine - 9 Mar 2016
Lee Sang Ho, Wang Hao, Labroli Marc, Koseoglu Sandra, Zuck Paul, Mayhood Todd, Gill Charles, Mann Paul, Sher Xinwei, Ha Sookhee, Yang Shu-Wei, Mandal Mihir, Yang Christine, Liang Lianzhu, Tan Zheng, Tawa Paul, Hou Yan, Kuvelkar Reshma, DeVito Kristine, Wen Xiujuan, Xiao Jing, Batchlett Michelle, Balibar Carl J, Liu Jenny, Xiao Jianying, Murgolo Nicholas, Garlisi Charles G, Sheth Payal R, Flattery Amy, Su Jing, Tan Christopher, Roemer Terry
Abstract excerpt
The widespread emergence of methicillin-resistant Staphylococcus aureus (MRSA) has dramatically eroded the efficacy of current β-lactam antibiotics and created an urgent need for new treatment options. We report an S. aureus phenotypic screening strategy involving chemical suppression of the growth inhibitory consequences of depleting late-stage wall teichoic acid biosynthesis. This enabled us to identify...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
